# carDIo-ttranSSfOrm nucLEar Imaging Study

> **NCT05259072** · — · TERMINATED · sponsor: **Oregon Health and Science University** · enrollment: 4 (actual)

## Conditions studied

- Amyloidosis
- Transthyretin Amyloid Cardiomyopathy

## Interventions

- **DIAGNOSTIC_TEST:** 99m-technetium pyrophosphate scintigraphy

## Key facts

- **NCT ID:** NCT05259072
- **Lead sponsor:** Oregon Health and Science University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2022-01-19
- **Primary completion:** 2023-12-30
- **Final completion:** 2023-12-30
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** Rolled over into another study
- **Last updated:** 2025-01-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05259072

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05259072, "carDIo-ttranSSfOrm nucLEar Imaging Study". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05259072. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*